Genotype-Dependent Difference in 5-HT2C Receptor-Induced Hypolocomotion : Comparison with 5-HT2A Receptor Functional Activity

In the present study behavioral effects of the 5-HT2C serotonin receptor were investigated in different mouse strains. The 5-HT2C receptor agonist MK-212 applied intraperitoneally induced significant dose-dependent reduction of distance traveled in the open field test in CBA/Lac mice. This effect wa...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Neural plasticity. - 1998. - 2015(2015) vom: 10., Seite 846589
1. Verfasser: Bazovkina, Darya V (VerfasserIn)
Weitere Verfasser: Kondaurova, Elena M, Naumenko, Vladimir S, Ponimaskin, Evgeni
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2015
Zugriff auf das übergeordnete Werk:Neural plasticity
Schlagworte:Comparative Study Journal Article Research Support, Non-U.S. Gov't 5-hydroxytryptamine2C receptor, mouse 8-(5-(5-amino-2,4-dimethoxyphenyl)-5-oxopentyl)-1,3,8-triazaspiro(4.5)decane-2,4-dione Amphetamines Pyrazines Receptor, Serotonin, 5-HT2A Receptor, Serotonin, 5-HT2C Serotonin 5-HT2 Receptor Agonists mehr... Spiro Compounds Sulfonamides 6-chloro-2-(1-piperazinyl)pyrazine 62C3N7238U 4-iodo-2,5-dimethoxyphenylisopropylamine OOM10GW9UE
LEADER 01000caa a22002652 4500
001 NLM252851005
003 DE-627
005 20250219040949.0
007 cr uuu---uuuuu
008 231224s2015 xx |||||o 00| ||eng c
024 7 |a 10.1155/2015/846589  |2 doi 
028 5 2 |a pubmed25n0842.xml 
035 |a (DE-627)NLM252851005 
035 |a (NLM)26380122 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Bazovkina, Darya V  |e verfasserin  |4 aut 
245 1 0 |a Genotype-Dependent Difference in 5-HT2C Receptor-Induced Hypolocomotion  |b Comparison with 5-HT2A Receptor Functional Activity 
264 1 |c 2015 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 19.04.2016 
500 |a Date Revised 13.11.2018 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a In the present study behavioral effects of the 5-HT2C serotonin receptor were investigated in different mouse strains. The 5-HT2C receptor agonist MK-212 applied intraperitoneally induced significant dose-dependent reduction of distance traveled in the open field test in CBA/Lac mice. This effect was receptor-specific because it was inhibited by the 5-HT2C receptor antagonist RS102221. To study the role of genotype in 5-HT2C receptor-induced hypolocomotion, locomotor activity of seven inbred mouse strains was measured after MK-212 acute treatment. We found that the 5-HT2C receptor stimulation by MK-212 decreased distance traveled in the open field test in CBA/Lac, C57Bl/6, C3H/He, and ICR mice, whereas it failed to affect locomotor activity in DBA/2J, Asn, and Balb/c mice. We also compared the interstrain differences in functional response to 5-HT2C and 5-HT2A receptors activation measured by the quantification of receptor-mediated head-twitches. These experiments revealed significant positive correlation between 5-HT2C and 5-HT2A receptors functional responses for all investigated mouse strains. Moreover, we found that 5-HT2A receptor activation with DOI did not change locomotor activity in CBA/Lac mice. Taken together, our data indicate the implication of 5-HT2C receptors in regulation of locomotor activity and suggest the shared mechanism for functional responses mediated by 5-HT2C and 5-HT2A receptors 
650 4 |a Comparative Study 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a 5-hydroxytryptamine2C receptor, mouse  |2 NLM 
650 7 |a 8-(5-(5-amino-2,4-dimethoxyphenyl)-5-oxopentyl)-1,3,8-triazaspiro(4.5)decane-2,4-dione  |2 NLM 
650 7 |a Amphetamines  |2 NLM 
650 7 |a Pyrazines  |2 NLM 
650 7 |a Receptor, Serotonin, 5-HT2A  |2 NLM 
650 7 |a Receptor, Serotonin, 5-HT2C  |2 NLM 
650 7 |a Serotonin 5-HT2 Receptor Agonists  |2 NLM 
650 7 |a Spiro Compounds  |2 NLM 
650 7 |a Sulfonamides  |2 NLM 
650 7 |a 6-chloro-2-(1-piperazinyl)pyrazine  |2 NLM 
650 7 |a 62C3N7238U  |2 NLM 
650 7 |a 4-iodo-2,5-dimethoxyphenylisopropylamine  |2 NLM 
650 7 |a OOM10GW9UE  |2 NLM 
700 1 |a Kondaurova, Elena M  |e verfasserin  |4 aut 
700 1 |a Naumenko, Vladimir S  |e verfasserin  |4 aut 
700 1 |a Ponimaskin, Evgeni  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Neural plasticity  |d 1998  |g 2015(2015) vom: 10., Seite 846589  |w (DE-627)NLM098558390  |x 1687-5443  |7 nnns 
773 1 8 |g volume:2015  |g year:2015  |g day:10  |g pages:846589 
856 4 0 |u http://dx.doi.org/10.1155/2015/846589  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_21 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 2015  |j 2015  |b 10  |h 846589